Cannabis Clinical Trials

TORONTO — Canopy Growth Corp., the largest of Canada’s publicly traded marijuana companies, is preparing to export its expertise through a new Brazilian partnership. Canopy’s Bedrocan subsidiary and its Brazilian partners have created a new company to import proprietary varieties of cannabis into Brazil — a country with a population of 200 million. Initially, Bedrocan Brazil will […]

Leonard Marshall of the New York Giants in 1991. Marshall believes he is suffering from CTE caused by head trauma from his playing days. When ex-Super Bowl champion Leonard Marshall took the stage at the Cannabis World Congress and Business Expo at the Javitz Center in New York on June 16, he still looked like […]

(Photo credit: Lew Robertson/Corbis) Marijuana extract reduces seizures in patients with Lennox-Gastaut Syndrome in clinical trial. GW Pharmaceuticals, the maker of a marijuana-based drug used to help children with rare forms of epilepsy, announced successful clinical trials of the drug Epidiolex in the treatment of Lennox-Gastaut Syndrome (LGS). Epidiolex is made from pharmaceutical-grade cannabidiol (CBD) […]

Michael Berger is a leading expert on the cannabis sector, a market that is just in its early stages of development. Here, the Associate Editor of highlights his favorite cannabis stock, GW Pharmaceuticals. GW Pharmaceuticals plc (GWPH) has once again changed the landscape of the cannabis industry as the company reported its second positive […]

Hundreds of advocates for marijuana legalization rallied and smoked pot outside the White House in April. (Photo by Marvin Joseph/The Washington Post) Rep. Andy Harris (R-Md.) is Congress’s most vocal opponent of legal marijuana, having single-handedly spearheaded a provision blocking legal pot shops in the District of Columbia in 2014. Rep. Earl Blumenauer (D-Ore.), on the other […]

The use of medical marijuana for millions of patients suffering from a wide range of health conditions and the subsequent therapeutic benefits has long been documented. Twenty-three states, the District of Columbia, Puerto Rico, and Guam, have determined that Cannabis sativa (a.k.a. marijuana) can benefit patients suffering from a wide range of conditions, including cancer, […]

Boston, MA–(ENEWSPF)–June 23, 2016.  Cannabis inhalation is associated with the alleviation of clinical symptoms in patients with bipolar disorder (BPD), according to clinical findings published in the open-access journal PLoS ONE. Investigators at Harvard Medical School and McLean Hospital in Boston assessed the effects of cannabis inhalation on mood and neuropsychological performance in patients with […]

While most people associate neurodegenerative disorders with diseases such as multiple sclerosis (MS), Alzheimer’s, or Parkinson disease, there are actually hundreds of different neurodegenerative diseases that affect millions of people worldwide. As legalization continues to bring cannabis to the forefront, caregivers and loved ones of patients afflicted with neurodegenerative diseases are increasingly curious about whether […]